Early tests of weight loss pills every day have helped people shed their pounds and reduce blood sugar levels, and they are competitors to join new drugs that fight obesity and diabetes.
According to the results of the three -stage clinical trial reported by the drug manufacturer, ELI Lilly, on Thursday, the 36mg pills of Orflipron have been lost 7.3kg (16LBS) for 9 months.
This test, which registered 559 obese people with type 2 diabetes in the United States, China, India, Japan, and Mexico, has led to less than the official threshold of diabetes.
The result of the trial is earnestly waiting for health researchers. Orforglipron is a daily pill version of the GLP-1 agent, a drug used for blockbuster weight loss injections such as Ozempic and Wegovy.
Ellie Lily’s chief executive David Ricks said:
In addition to the results, the company said in a statement that the drug met the expectation of safety, tolerability, glucose control and weight loss.
Weight loss JABS has become popular, but health officials believe that more people can adjust their weight and blood sugar levels with more daily pills. In the UK, two -thirds of adults are overweight or obese, and more than 5 million people suffer from type 2 diabetes.
According to the 40 -week exam, blood sugar decreased from 1.2% to 1.5% by taking 3 mg, 12mg or 36mg every day. During the same period, the participants had a weight of 4.5%in 3mg pills, 5.8%in 12mg pills, and 7.6%in 36mg pills.
After the newsletter promotion
The results will be presented at the US Diabetes Association Meeting in June before being published in a fellow review journal. The company said it will apply for approval to market the drug for the late 2 year and next year.
Naveed Sattar, a professor of heart metabolic at the University of Glasgow, said: “This is an important result. A new oral preparation that lowers glucose is also a low level of low levels found in most existing diabetes therapy. One of the courses will not know the effect of this new therapy.
